Philogen

Developer of antibody based drugs for angiogenesis-related cancer and inflammatory disorders

placeSovicille, Tuscany, Italy calendar_todayFounded 1996 groups157 employees language philogen.com

Innovation

103 patent families (47 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 7,756 times.

YearFilings
201525
201625
201726
201823
201925
202028
202115
202211
202312
202412
202510
20263

Social engagement

Social engagement: 33K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include The Equity Club.

Investor typeCountShare
Venture capital240%
Private equity240%
Other / undisclosed120%

Recent activity

17 Jun 2026
Milestone
anniversary
19 Apr 2026
Event
AACR 2026
25 Mar 2026
Event
webinar on upcoming webinar
Coming soon